FIELD: medicine.
SUBSTANCE: invention represents a drug for treating osteoarthrosis presented as a soft dosage form, containing glucosamine and methyl salicylate as active substances, and additive agents.
EFFECT: enhanced anaesthetic action and lower toxicity of methyl salicylate.
10 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRANSDERMAL AGENT FOR TREATING AND PREVENTING JOINT AND SOFT TISSUE DISEASES, METHOD FOR PRODUCTION THEREOF AND COMBINED TRANSDERMAL PREPARATION FOR TREATING AND PREVENTING JOINT AND SOFT TISSUE DISEASES | 2013 |
|
RU2582278C2 |
| TRANSDERMAL PREPARATION FOR TREATMENT AND PREVENTION OF DISEASES OF JOINTS AND SOFT TISSUES | 2018 |
|
RU2685436C1 |
| METHOD FOR PREVENTING AND TREATING ARTHROPATHIES AND METHODS FOR USING SAME | 2013 |
|
RU2521973C1 |
| COMPOSITION CONTAINING CHONDROITIN SULPHATE AND HYALURONIDASE | 2013 |
|
RU2539390C1 |
| AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2259204C1 |
| AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2260432C1 |
| PHARMACEUTICAL COMPOSITION IN GEL MEDICINAL FORM FOR LOCAL USE ON THE BASIS OF N-(2-ADAMANTIL)-HEXAMETHYLENEMINE HYDROCHLORIDE | 2017 |
|
RU2663452C1 |
| AGENT FOR TREATMENT OF JOINT DISEASE | 2004 |
|
RU2271812C1 |
| AGENT FOR TREATMENT OF JOINT DISEASE | 2004 |
|
RU2271811C1 |
| EXTERNAL PREPARATION FOR TREATING ARTHROPATHIES AND SOFT TISSUE CONDITIONS | 2007 |
|
RU2377974C2 |
